NCT07133230

Brief Summary

Linguistic irregularities in number naming systems, such as the inversion of number words, affect the processing of Arabic numerals. Recently, it has been claimed that there is even a syntactic representation of number words. participant investigate the neurofunctional correlates of the syntactic processing of number words by examining different levels of place-value processing in a study with two complementary successive phases (Group 1 and Group 2) in healthy adults. In the first phase with Group 1, participant evaluate the unit-decade compatibility effect (UDCE) in two-digit magnitude comparisons. In the second phase with Group 2, participant investigate the carry-over effect in two-digit addition problems.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for all trials

Timeline
18mo left

Started Sep 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Sep 2025Oct 2027

First Submitted

Initial submission to the registry

June 12, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 20, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2027

Last Updated

August 20, 2025

Status Verified

May 1, 2025

Enrollment Period

2.1 years

First QC Date

June 12, 2025

Last Update Submit

August 19, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Neurofunctional variables (fMRI)

    the comparison of pairs of incompatible numbers compared to pairs of compatible numbers during the comparison of numbers.

    Day 1

  • Structural variables (structural MRI)

    the comparison of problems of addition with and without restraint during mental arithmetic.

    Day 1

  • Behavioral variables,

    we compare performance to the post-imaging reading test

    Day 1

  • structural variables

    recording of morphological and brain morphometric characteristics.

    Day 1

Secondary Outcomes (2)

  • Handedness score

    Day 1

  • Demographics questionnaire

    Day 1

Study Arms (2)

Participants recruited (phase 1)

In each experimental phase (2 in total), 42 adult volunteers will be recruited (a total of 84 participants), selected based on the following criteria: * Aged 18-45 * Female or male * Right-handed * Signed informed consent * Normal medical, neurological, and neuroradiological examinations * Affiliated with a social security system * For women of childbearing age: under effective contraception; a urine pregnancy test will be administered * MRI examination compatible Participants will be recruited in the Paris region.

Participants recruited (phase 2)

In each experimental phase (2 in total), 42 adult volunteers will be recruited (a total of 84 participants), selected based on the following criteria: * Aged 18-45 * Female or male * Right-handed * Signed informed consent * Normal medical, neurological, and neuroradiological examinations * Affiliated with a social security system * For women of childbearing age: under effective contraception; a urine pregnancy test will be administered * MRI examination compatible Participants will be recruited in the Paris region.

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

In the experimental phase, 42 adult volunteers (a total of 84), selected according to strict criteria, will undergo an MRI scan, each comprising: - anatomical acquisition, - functional acquisition of activation during a number processing task (Phase 1: two-digit number magnitude comparison; Phase 2: multi-digit mental arithmetic).

You may qualify if:

  • Subject aged 18 to 45 years;
  • Female or male;
  • Right-handed preference;
  • Subject, or legal representative, who has given consent to participate;
  • Native language: French
  • Subject affiliated with a social security system;
  • Having signed their consent to participate (and their legal representative if applicable),
  • Subjects have read the information letter and given their free and informed consent;
  • Normal medical, neurological, and neuroradiological examinations
  • For women of childbearing age, be on effective contraception

You may not qualify if:

  • Not corresponding to the targeted age range;
  • Subject with contraindications to an MRI examination (pacemaker or neurosensory stimulator or implantable defibrillator, cochlear implants, ferromagnetic foreign bodies in the eyes or brain near neural structures, metal prostheses, patient agitation: non-cooperative or agitated patients, minors, claustrophobic subjects, pregnant women, ventriculoperitoneal neurosurgical shunt valves, dental braces);
  • Subject with chronic alcohol or drug use;
  • Abuse or dependence on substances (except nicotine) or toxic substances for more than 5 years or having led to comas (overdoses);
  • Subject with sudden-onset cognitive disorders that could indicate a stroke; a history of head trauma with loss of consciousness for more than 1 hour, or encephalitis;
  • Subject with chronic neurological, psychiatric, endocrine, hepatic, or infectious conditions;
  • Subject with a history of major illness (diabetes, chronic lung disease, severe cardiac, metabolic, hematological, endocrine, or immunological disorder, cancer);
  • Subject on medication: taking medications likely to interfere with brain imaging measurements (psychotropics, anxiolytic hypnotics, neuroleptics, anti-Parkinsonians, benzodiazepines, steroidal anti-inflammatories, antiepileptics, central analgesics, and muscle relaxants);
  • Color blindness;
  • Inability to comply with the study for geographical or psychiatric reasons;
  • Tattoo incompatible with MRI;
  • Cerebral palsy;
  • Fine motor skills disorder;
  • Adult subjects under legal protection or unable to give consent (article L.1121-8 of the French Public Health Code) (under guardianship or curatorship);
  • Children and parents under legal protection measures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GHU Ste Anne

Paris, 75014, France

Location

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2025

First Posted

August 20, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 30, 2027

Last Updated

August 20, 2025

Record last verified: 2025-05

Locations